Is a complete OPRX research report available?

No complete published report is available for OptimizeRx Corporation (OPRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · USD

$9.26

+0.20 (+2.2%)· Recorded snapshot

Market cap	174.4M
Revenue (ttm)	98.7M
Net income (ttm)	4.6M
EPS (ttm)	$0.25
Shares out	18.8M
P/E (trailing)	37.6x
P/E (forward)	10.0x
Volume	86,915
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001448431
Company name	OptimizeRx Corporation
Country	United States
Country code	US
CUSIP number	68401U204
Earnings date	2026-11-11
Earnings time	amc
Employees	133
Employees change	4
Employees growth	3.1%
Enterprise value	$169.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Health Information Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US68401U2042
Last 10-K release date	2026-03-12
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2018-05-14
Last stock split type	Reverse
Market cap	$174.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$9.26
Price currency	USD
Sector	Healthcare
SIC code	7389
Stock price date	2026-10-28
Symbol	OPRX
U.S. state	Massachusetts
Website	https://www.optimizerx.com

Metric

Value

Amount currency

USD

CIK code

0001448431

Company name

OptimizeRx Corporation

Country

United States

Country code

CUSIP number

68401U204

Earnings date

2026-11-11

Earnings time

amc

Employees

133

Employees change

Employees growth

3.1%

Enterprise value

$169.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

Industry

Health Information Services

Is primary listing

Yes

Is SPAC

ISIN number

US68401U2042

Last 10-K release date

2026-03-12

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2018-05-14

Last stock split type

Reverse

Market cap

$174.4M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$9.26

Price currency

USD

Sector

Healthcare

SIC code

7389

Stock price date

2026-10-28

Symbol

OPRX

U.S. state

Massachusetts

Website

https://www.optimizerx.com

Metric	Value
Adjusted P/E ratio	9.17x
Earnings yield	2.66%
EV/Earnings	36.09x
EV/EBIT	14.74x
EV/EBITDA	10.68x
EV/FCF	9.04x
EV/Sales	1.68x
FCF / EV yield	11.06%
FCF yield	10.76%
Forward EV/Sales	1.66x
Forward P/E	10.03x
Forward P/S	1.71x
Graham number	6.20795
Graham upside	-31.48%
Industry forward P/E	34.7x
Lynch fair value	$6.15
Lynch upside	-32.1%
P/(FCF - SBC) ratio	16.4x
P/(OCF - SBC) ratio	16.28x
P/B ratio	1.3x
P/E ratio	37.63x
P/FCF ratio	9.3x
P/OCF ratio	9.26x
P/S ratio	1.73x
Price / tangible book value	7.94x
Price/EBITDA ratio	10.97x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

9.17x

Earnings yield

2.66%

EV/Earnings

36.09x

EV/EBIT

14.74x

EV/EBITDA

10.68x

EV/FCF

9.04x

EV/Sales

1.68x

FCF / EV yield

11.06%

FCF yield

10.76%

Forward EV/Sales

1.66x

Forward P/E

10.03x

Forward P/S

1.71x

Graham number

6.20795

Graham upside

-31.48%

Industry forward P/E

34.7x

Lynch fair value

$6.15

Lynch upside

-32.1%

P/(FCF - SBC) ratio

16.4x

P/(OCF - SBC) ratio

16.28x

P/B ratio

1.3x

P/E ratio

37.63x

P/FCF ratio

9.3x

P/OCF ratio

9.26x

P/S ratio

1.73x

Price / tangible book value

7.94x

Price/EBITDA ratio

10.97x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	11.42%
EBITDA margin	15.76%
Effective tax rate	31.85%
FCF margin	18.61%
Gross margin	73.22%
Operating margin	11.42%
Pretax margin	6.84%
Profit margin	4.66%
Profit per employee	$34,594
Profitable years	1
Revenue per employee	$741,759
ROA	4.22%
ROA (5Y)	-1.67%
ROCE	7.29%
ROE	3.68%
ROE (5Y)	-6.94%
ROIC	5.91%
ROIC (5Y)	-6.92%
SBC / revenue	8.06%
Tax / revenue	2.18%

Metric

Value

EBIT margin

11.42%

EBITDA margin

15.76%

Effective tax rate

31.85%

FCF margin

18.61%

Gross margin

73.22%

Operating margin

11.42%

Pretax margin

6.84%

Profit margin

4.66%

Profit per employee

$34,594

Profitable years

Revenue per employee

$741,759

ROA

4.22%

ROA (5Y)

-1.67%

ROCE

7.29%

ROE

3.68%

ROE (5Y)

-6.94%

ROIC

5.91%

ROIC (5Y)

-6.92%

SBC / revenue

8.06%

Tax / revenue

2.18%

Metric	Value
EPS growth 5Y	42.62%
EPS growth years	1
FCF growth	77.5%
FCF growth (Q)	88.44%
FCF growth 3Y	70.22%
Gross profit growth	7.1%
Gross profit growth (Q)	-15.81%
Gross profit growth 3Y	24.83%
Gross profit growth 5Y	20.2%
Net income growth 5Y	42.28%
Net income growth years	1
OCF growth	77.01%
OCF growth (Q)	88.8%
OCF growth 10Y	69.98%
OCF growth 3Y	69.12%
Operating income growth	188.16%
Operating income growth 5Y	44.44%
Revenue growth	-5.82%
Revenue growth (Q)	-29.77%
Revenue growth (QoQ)	3.33%
Revenue growth 10Y	29.05%
Revenue growth 3Y	17.02%
Revenue growth 5Y	13.75%
Revenue growth years	16

Metric

Value

EPS growth 5Y

42.62%

EPS growth years

FCF growth

77.5%

FCF growth (Q)

88.44%

FCF growth 3Y

70.22%

Gross profit growth

7.1%

Gross profit growth (Q)

-15.81%

Gross profit growth 3Y

24.83%

Gross profit growth 5Y

20.2%

Net income growth 5Y

42.28%

Net income growth years

OCF growth

77.01%

OCF growth (Q)

88.8%

OCF growth 10Y

69.98%

OCF growth 3Y

69.12%

Operating income growth

188.16%

Operating income growth 5Y

44.44%

Revenue growth

-5.82%

Revenue growth (Q)

-29.77%

Revenue growth (QoQ)

3.33%

Revenue growth 10Y

29.05%

Revenue growth 3Y

17.02%

Revenue growth 5Y

13.75%

Revenue growth years

Metric	Value
Capital expenditures	$-77,000
Depreciation and amortization	$4.3M
EBIT	$11.3M
EBITDA	$15.6M
EPS	$0.25
FCF per share	$0.97
Financing cash flow	$-11.1M
Free cash flow	$18.4M
Free cash flow minus SBC	$10.4M
Gross profit	$72.2M
Income taxes	$2.2M
Investing cash flow	$140,000
Net borrowing	$-10.3M
Net cash flow	$7.5M
Net income	$4.6M
Operating cash flow minus SBC	$10.5M
Operating income	$11.3M
Revenue	$98.7M
Stock-based compensation	$8M

Metric

Value

Capital expenditures

$-77,000

Depreciation and amortization

$4.3M

EBIT

$11.3M

EBITDA

$15.6M

EPS

$0.25

FCF per share

$0.97

Financing cash flow

$-11.1M

Free cash flow

$18.4M

Free cash flow minus SBC

$10.4M

Gross profit

$72.2M

Income taxes

$2.2M

Investing cash flow

$140,000

Net borrowing

$-10.3M

Net cash flow

$7.5M

Net income

$4.6M

Operating cash flow minus SBC

$10.5M

Operating income

$11.3M

Revenue

$98.7M

Stock-based compensation

$8M

Metric	Value
Altman Z-Score	4.46
Book value per share	$6.96
Debt / EBITDA	1.23
Debt / equity	0.15
Debt / FCF	1.06
Goodwill	$70.9M
Interest coverage	2.41
Long-term assets	$110.2M
Long-term liabilities	$23.5M
Net cash (debt)	$4.6M
Net cash / market cap	2.7%
Net debt / EBITDA	-0.3
Net debt / equity	-0.04
Net debt / FCF	-0.25
Piotroski F-Score	7
Property, plant and equipment	$574,000
Shareholders' equity	$131.1M
Tangible book value	$21.5M
Tangible book value per share	$1.14
Total assets	$164.3M
Total cash	$24.1M
Total debt	$19.5M
Total liabilities	$33.2M
WACC	11.71%

Metric

Value

Altman Z-Score

4.46

Book value per share

$6.96

Debt / EBITDA

1.23

Debt / equity

0.15

Debt / FCF

1.06

Goodwill

$70.9M

Interest coverage

2.41

Long-term assets

$110.2M

Long-term liabilities

$23.5M

Net cash (debt)

$4.6M

Net cash / market cap

2.7%

Net debt / EBITDA

-0.3

Net debt / equity

-0.04

Net debt / FCF

-0.25

Piotroski F-Score

Property, plant and equipment

$574,000

Shareholders' equity

$131.1M

Tangible book value

$21.5M

Tangible book value per share

$1.14

Total assets

$164.3M

Total cash

$24.1M

Total debt

$19.5M

Total liabilities

$33.2M

WACC

11.71%

Metric	Value
Asset turnover	0.59
Current assets	$54.1M
Current liabilities	$9.7M
Current ratio	5.58
Net working capital	$21.8M
Quick ratio	5.27
Working capital	$44.4M
Working capital turnover	2.55

Metric

Value

Asset turnover

0.59

Current assets

$54.1M

Current liabilities

$9.7M

Current ratio

5.58

Net working capital

$21.8M

Quick ratio

5.27

Working capital

$44.4M

Working capital turnover

2.55

Metric	Value
Buyback yield / dilution	-3.84%
Dividend yield	0%
Shareholder yield	-3.84%

Metric

Value

Buyback yield / dilution

-3.84%

Dividend yield

Shareholder yield

-3.84%

Metric	Value
10Y price change	225.97%
10Y return CAGR	12.54%
10Y total return	225.96%
150-day SMA	$6.80
15Y price change	129.38%
15Y return CAGR	5.69%
15Y total return	129.38%
1D price change	2.21%
1M price change	15.55%
1M total return	15.55%
1W price change	4.03%
1W total return	4.03%
1Y price change	-55.51%
1Y return CAGR	-55.53%
1Y total return	-55.51%
20-day SMA	$8.73
200-day SMA	$7.33
20Y price change	-99.24%
20Y return CAGR	-21.66%
20Y total return	-99.24%
3M price change	45.61%
3M total return	45.61%
3Y price change	21.44%
3Y return CAGR	6.69%
3Y total return	21.44%
50-day SMA	$8.15
50-day SMA vs 200-day SMA	50over200
52-week high	$21.56
52-week high date	2025-10-29
52-week low	$4.54
52-week low date	2026-06-23
5Y price change	-90.16%
5Y return CAGR	-37.11%
5Y total return	-90.16%
6M price change	44.93%
6M total return	44.93%
All-time high	$6,000.06
All-time high date	2006-12-18
All-time low	$0.60
All-time low date	2009-09-24
Average true range (ATR)	$0.45
Average volume	143.9K
Beta (1Y)	2.04
Beta (2Y)	2.03
Beta (5Y)	1.26
Change from 52-week high	-57.05%
Change from 52-week low	103.97%
Change from all-time high	-99.85%
Change from all-time low	1,448.33%
Change from open	-0.64%
Day's gap	2.87%
Dollar volume	$804,833
High price	$9.32
Low price	$9.20
Monthly RSI	47.46
Open price	$9.32
Position in 52-week range	50%
Previous close	$9.06
Price vs 150-day SMA	36.68%
Price vs 20-day SMA	6.37%
Price vs 200-day SMA	26.7%
Price vs 50-day SMA	14.03%
Relative volume	0.6
RSI	63.79
Sharpe ratio	-0.87
Sharpe ratio (3Y)	0.38
Sharpe ratio (5Y)	-0.28
Sortino ratio	-1.1
Sortino ratio (3Y)	0.71
Sortino ratio (5Y)	-0.34
Volume	86.9K
Weekly RSI	59.45
YTD price change	-24.23%
YTD total return	-24.23%

Metric

Value

10Y price change

225.97%

10Y return CAGR

12.54%

10Y total return

225.96%

150-day SMA

$6.80

15Y price change

129.38%

15Y return CAGR

5.69%

15Y total return

129.38%

1D price change

2.21%

1M price change

15.55%

1M total return

15.55%

1W price change

4.03%

1W total return

4.03%

1Y price change

-55.51%

1Y return CAGR

-55.53%

1Y total return

-55.51%

20-day SMA

$8.73

200-day SMA

$7.33

20Y price change

-99.24%

20Y return CAGR

-21.66%

20Y total return

-99.24%

3M price change

45.61%

3M total return

45.61%

3Y price change

21.44%

3Y return CAGR

6.69%

3Y total return

21.44%

50-day SMA

$8.15

50-day SMA vs 200-day SMA

50over200

52-week high

$21.56

52-week high date

2025-10-29

52-week low

$4.54

52-week low date

2026-06-23

5Y price change

-90.16%

5Y return CAGR

-37.11%

5Y total return

-90.16%

6M price change

44.93%

6M total return

44.93%

All-time high

$6,000.06

All-time high date

2006-12-18

All-time low

$0.60

All-time low date

2009-09-24

Average true range (ATR)

$0.45

Average volume

143.9K

Beta (1Y)

2.04

Beta (2Y)

2.03

Beta (5Y)

1.26

Change from 52-week high

-57.05%

Change from 52-week low

103.97%

Change from all-time high

-99.85%

Change from all-time low

1,448.33%

Change from open

-0.64%

Day's gap

2.87%

Dollar volume

$804,833

High price

$9.32

Low price

$9.20

Monthly RSI

47.46

Open price

$9.32

Position in 52-week range

50%

Previous close

$9.06

Price vs 150-day SMA

36.68%

Price vs 20-day SMA

6.37%

Price vs 200-day SMA

26.7%

Price vs 50-day SMA

14.03%

Relative volume

0.6

RSI

63.79

Sharpe ratio

-0.87

Sharpe ratio (3Y)

0.38

Sharpe ratio (5Y)

-0.28

Sortino ratio

-1.1

Sortino ratio (3Y)

0.71

Sortino ratio (5Y)

-0.34

Volume

86.9K

Weekly RSI

59.45

YTD price change

-24.23%

YTD total return

-24.23%

Metric	Value
Float	14.5M
Float percentage	76.86%
Shares change (QoQ)	0.13%
Shares change (YoY)	3.84%
Shares held by insiders	15.14%
Shares held by institutions	61.59%
Shares outstanding	18.8M
Short % of float	7.71%
Short % of shares	5.93%
Short ratio	7.2 days

Metric

Value

Float

14.5M

Float percentage

76.86%

Shares change (QoQ)

0.13%

Shares change (YoY)

3.84%

Shares held by insiders

15.14%

Shares held by institutions

61.59%

Shares outstanding

18.8M

Short % of float

7.71%

Short % of shares

5.93%

Short ratio

7.2 days

OptimizeRx Corporation (OPRX)

Price

Financial snapshot

Fair-value bridge

Latest news · OPRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OPRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OPRX

Frequently asked questions